Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

How Common Is Anaphylaxis Following Vaccination?

By Jan 18, 2019

To investigate the incidence of anaphylaxis after vaccination, study authors reviewed data submitted to the Vaccine Adverse Event Reporting System (VAERS) between 1990 and 2016.

FDA: Paclitaxel-Coated Devices for PAD Potentially Tied to Increased Mortality

By Jan 17, 2019

The FDA's communication follows a recent meta-analysis published in the Journal of the American Heart Association (JAHA).

Seysara Now Available for Moderate-to-Severe Acne Vulgaris

By Jan 17, 2019

The approval was based on data from 2 large, multicenter, randomized, double-blind, placebo-controlled Phase 3 trials involving patients with moderate to severe acne vulgaris.

Symjepi Now Available for Emergency Treatment of Allergic Reactions

By Jan 17, 2019

The product will be made available first in institutions followed by a launch in the retail setting.

First Generic Version of Sabril Tablets Gets FDA Approval

By Jan 16, 2019

As treatment with vigabatrin may be associated with permanent vision loss, the generic tablets are also part of a single shared-system Risk Evaluation and Mitigation Strategy (REMS) program to ensure the product is used safely.

More Articles by Da Hee Han, PharmD